Showing results (881-890 of 1,072) with videos related to

Sort By:
Pageof 108
Annals of Hematology|January 15, 2025
Efficacy and safety of olverembatinib as maintenance therapy after allogeneic hematopoietic cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemiaJun Kong, Feng-Mei Zheng, Chen-Hua Yan, et al.
Zhonghua Nei Ke Za Zhi|January 19, 2013
[The efficacy and safety of rituximab in treatment of Epstein-Barr virus disease post allogeneic hematopoietic stem-cell transplantation]Lan-ping Xu, Dai-hong Liu, Kai-yan Liu, et al.
Cancer Communications (London, England)|October 24, 2022
Optimized therapeutic strategy for patients with refractory or relapsed acute myeloid leukemia: long-term clinical outcomes and health-related quality of life assessmentChen-Hua Yan, Yu Wang, Yu-Qian Sun, et al.
Neurology|October 9, 2015
Paroxysmal kinesigenic dyskinesia: Clinical and genetic analyses of 110 patientsXiao-Jun Huang, Tian Wang, Jun-Ling Wang, et al.
The Lancet. Haematology|September 18, 2017
Oral all-trans retinoic acid plus danazol versus danazol as second-line treatment in adults with primary immune thrombocytopenia: a multicentre, randomised, open-label, phase 2 trialFei-Er Feng, Ru Feng, Min Wang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 9, 2014
Extramedullary relapse of acute leukemia after haploidentical hematopoietic stem cell transplantation: incidence, risk factors, treatment, and clinical outcomesXiao-Dong Mo, Jun Kong, Ting Zhao, et al.
Blood|December 29, 2005
Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantationDao-Pei Lu, Lujia Dong, Tong Wu, et al.
Blood Cell Therapy|June 9, 2025
PD-1 inhibitor in patients with minimal residual disease who failed donor lymphocyte infusion or interferon after allogeneic haematopoietic stem cell transplantationLing Ma, Si-Qi Li, Wei Han, et al.
Clinical and Experimental Medicine|May 13, 2026
Ultra-Low BCR::ABL1 positivity by digital PCR does not improve post-transplant risk stratification beyond real-time PCR in Ph+ acute lymphoblastic leukemia post-transplantYa Luo, Wen-Min Chen, Xiao-Su Zhao, et al.
Scientific Reports|February 13, 2020
Prevalence and risk factors of having antibodies to class I and II human leukocyte antigens in older haploidentical allograft candidatesLe-Qing Cao, Meng Lv, Lan-Ping Xu, et al.
Pageof 108